Canada markets close in 2 hours 55 minutes

Talphera, Inc. (TLPH)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.0334-0.0466 (-4.33%)
As of 01:01PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close1.0800
Open1.1100
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.0301 - 1.1100
52 Week Range0.4300 - 1.6100
Volume23,548
Avg. Volume79,595
Market Cap17.561M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateAug 08, 2024 - Aug 12, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.42
  • PR Newswire

    Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

    Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that the Board of Directors of Talphera has granted inducement awards consisting of a non-statutory time-based stock option to purchase 185,000 shares of common stock and a time-based restricted stock unit award for 32,000 shares of common stock on May 20, 2024 to Dr. Shakil Aslam in conn

  • PR Newswire

    Talphera to Participate at A.G.P. Virtual Healthcare Conference

    Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that management will participate in a fireside chat at the A.G.P. Virtual Healthcare conference May 21, 2024 at 10:40 a.m. ET.

  • PR Newswire

    Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update

    Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced first quarter 2024 financial results and provided a corporate update.